Ordinal Score Predicts Freedom From Epilepsy One Year After Surgery

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 5, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, Nov. 5, 2024 -- An ordinal score incorporating eight independent binary clinical variables shows good performance for predicting seizure freedom one year after surgery for mesial temporal lobe epilepsy, according to a study published in the September issue of the Annals of Clinical and Translational Neurology.

Adam S. Dickey, M.D., Ph.D., from Emory University in Atlanta, and colleagues predicted one-year seizure freedom using a combination of eight relevant clinical variables. The analysis included 101 patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy.

The researchers found that significant predictors for seizure freedom were evidence of mesial temporal sclerosis and unitemporal interictal discharges in a univariate analysis. The ordinal SCORE model, built using a 0- to 8-point ordinal score awarding 1 point for each binary predictor, had a significantly higher area under the curve (AUC, 0.70) than the other three models: mesial temporal sclerosis (AUC, 0.54), FULL, using all eight binary predictors (AUC, 0.62), or Akaike information criteria, using backwards selection of variables (AUC, 0.53).

"Our overall conclusion is that the concordance of multiple clinical datapoints better predicts seizure freedom after SLAH than any one datapoint alone," the authors write. "Future research will incorporate additional data -- such as semiology and neuropsychological profile -- into the ordinal score described here."

Several authors disclosed ties to Medtronic, and SLAH was performed using a Medtronic laser ablation system.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-11-06 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords